Thousands of cases of multisystem inflammatory syndrome in children (and dozens of resultant deaths) moved COVID-19 infection among pediatric patients from “no big deal” to cause for serious concern. It didn’t take long for intravenous immunoglobulin (IVIG) plus corticosteroids to emerge as a viable treatment. The question of whether that was the best option followed shortly thereafter—with the answer being not necessarily, according to an article just published by JAMA Pediatrics. The retrospective cohort study …
Read More